ANAB
AnaptysBio Inc.
$57.77
-$1.94(-3.25%)
46
Overall
40
Value
54
Tech
44
Quality
Market Cap
$1.13B
Volume
482.16K
52W Range
$17.11 - $73.30
Target Price
$81.50
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $10.0M | $5.0M | $8.0M | $75.0M | $63.2M | $10.3M | $17.2M | $91.3M | $234.6M | ||
| Total Revenue | $10.0M | $5.0M | $8.0M | $75.0M | $63.2M | $10.3M | $17.2M | $91.3M | $234.6M | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $10.0M | $5.0M | $8.0M | $75.0M | $63.2M | $10.3M | $17.2M | $91.3M | $234.6M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $-38.8M | $-71.7M | $115.4M | $98.9M | $120.0M | $125.4M | $181.6M | $206.2M | $186.7M | ||
| Research & Development | $29.4M | $56.2M | $99.3M | $80.0M | $98.5M | $88.8M | $139.6M | $163.8M | $136.0M | ||
| Research Expense | $29.4M | $56.2M | $99.3M | $80.0M | $98.5M | $88.8M | $132.3M | $163.8M | $136.0M | ||
| Selling, General & Administrative | $9.3M | $15.5M | $16.1M | $18.9M | $21.5M | $36.6M | $41.9M | $42.4M | $50.7M | ||
| General & Administrative Expenses | $9.3M | $15.5M | $16.1M | $18.9M | $21.5M | $36.6M | $41.9M | $42.4M | $50.7M | ||
| Salaries & Wages | -- | -- | -- | -- | -- | $27.4M | -- | -- | -- | ||
| Other Operating Expenses | $-182.0K | $-1.2M | $-1.2M | $-898.0K | $-984.0K | $-896.0K | -- | -- | -- | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-38.8M | $-66.7M | $-107.4M | $-23.9M | $-56.8M | $-115.2M | $-164.4M | $-114.9M | $47.9M | ||
| EBITDA | $-28.1M | $-61.1M | $-98.6M | $-18.3M | $-54.3M | $-105.3M | $-161.2M | $-142.8M | $-10.6M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | $1.8M | $1.7M | $1.0M | -- | $1.4M | $21.1M | $18.1M | $50.1M | -- | ||
| Intinc | $1.6M | $6.7M | $11.0M | $4.0M | $431.0K | $7.5M | $18.9M | $19.8M | $13.5M | ||
| Net Non-Operating Interest Income/Expense | $-152.0K | $5.0M | $9.9M | $4.0M | $431.0K | $13.6M | $18.9M | $19.8M | $13.5M | ||
| Other Income/Expense | $-8.9M | $159.0K | $-1.0K | $11.0K | $1.4M | $12.0K | $2.0K | $-14.0K | $-5.4M | ||
| Other Special Charges | $8.9M | $-159.0K | $1.0K | $-11.0K | $-1.4M | $12.0K | $-2.0K | $14.0K | $5.4M | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-28.3M | $-60.2M | $-96.4M | $-19.9M | $-56.3M | $-107.6M | $-163.6M | $-145.2M | $-13.1M | ||
| Pre-Tax Income | $-30.1M | $-61.8M | $-97.5M | $-19.9M | $-57.8M | $-128.7M | $-163.6M | $-145.2M | $-13.1M | ||
| INCOME TAX | |||||||||||
| Tax Provision | $-7.6M | $-192.0K | $-152.0K | $-21.0K | $-142.0K | $24.0K | $-4.0K | $3.0K | $164.0K | ||
| NET INCOME | |||||||||||
| Net Income | $-30.1M | $-61.7M | $-97.3M | $-19.9M | $-57.8M | $-128.7M | $-163.6M | $-145.2M | $-13.2M | ||
| Net Income (Continuing Operations) | $-30.1M | $-61.7M | $-97.3M | $-19.9M | $-57.8M | $-128.7M | $-163.6M | $-145.2M | $-13.2M | ||
| Net Income (Discontinued Operations) | $-30.1M | $-61.7M | $-97.3M | $-19.9M | $-57.8M | $-128.7M | $-163.6M | $-145.2M | $-13.2M | ||
| Net Income (Common Stockholders) | $-30.1M | $-61.7M | $-97.3M | $-19.9M | $-57.8M | $-128.7M | $-163.6M | $-145.2M | $-13.2M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | $-12.9M | ||
| TOTALS | |||||||||||
| Total Expenses | $-38.8M | $-71.7M | $115.4M | $98.9M | $120.0M | $125.4M | $181.6M | $206.2M | $186.7M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $19.8M | $24.7M | $27.1M | $27.3M | $27.4M | $28.2M | $26.9M | $28.4M | $28.8M | ||
| Average Shares Outstanding (Diluted) | $19.8M | $24.7M | $27.1M | $27.3M | $27.4M | $28.2M | $26.9M | $28.4M | $28.8M | ||
| Shares Outstanding | $23.8M | $27.0M | $27.3M | $27.4M | $29.1M | $27.9M | $26.8M | $30.7M | $28.7M | ||
| Basic EPS | $-1.52 | $-2.5 | $-3.6 | $-0.73 | $-2.11 | $-4.57 | $-6.08 | $-5.12 | $-0.46 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-3.6 | $-0.73 | $-2.11 | $-4.57 | $-6.08 | $-5.12 | $-0.46 | ||
| Diluted EPS | $-1.52 | $-2.5 | $-3.6 | $-0.73 | $-2.11 | $-4.57 | $-6.08 | $-5.12 | $-0.46 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-3.6 | -- | $-2.11 | $-4.57 | $-6.08 | $-5.12 | $-0.46 | ||
| OTHER METRICS | |||||||||||
| Development Expense | -- | -- | -- | -- | -- | -- | $7.3M | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | $100.0K | -- | -- | -- | -- | -- | ||
| Other Gand A | $9.3M | $15.5M | $16.1M | $18.9M | $21.5M | $36.6M | $41.9M | $42.4M | $50.7M | ||
| Rent And Landing Fees | $9.3M | $15.5M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANAB | $57.77 | -3.2% | 482.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |